Large Insider Purchases
Institutional-Scale SEC Form 4 Buy Signals
The Signal of $1M+ Conviction
When a corporate executive invests more than $1,000,000 of their own capital into company shares, it represents the highest level of conviction. These seven-figure purchases reflect management's belief in the company's future value.
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2018-05-31 23:13 | 2018-05-29 | KNSA | Kiniksa Pharmaceuticals International, plc | Cormorant Asset Management, LP | 10% owner | Pharmaceutical Preparations | BUY | $18.00 | 69,444 | $1,249,992 | 900,443 | +8.4% |
| 2018-06-01 04:42 | 2018-05-29 | SRRK | Scholar Rock Holding Corp | Nashat Amir | Director, 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $14.00 | 142,857 | $1,999,998 | 156,395 | +1,055.2% |
| 2018-06-01 04:43 | 2018-05-29 | SRRK | Scholar Rock Holding Corp | Polaris Venture Management Co. VI, L.L.C. | 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $14.00 | 142,857 | $1,999,998 | 156,395 | +1,055.2% |
| 2018-06-01 01:12 | 2018-05-29 | NVT | nVent Electric plc | Baldwin Brian M | Director | Special Industry Machinery (No Metalworking Machinery) | BUY | $26.70 | 698,998 | $18,664,575 | 17,557,868 | +4.1% |
| 2018-05-31 23:54 | 2018-05-30 | ITRM | Iterum Therapeutics plc | Lathi Vijay K | 10% owner | Pharmaceutical Preparations | BUY | $13.00 | 662,677 | $8,614,801 | 384,615 | +100.0% |
| 2018-05-31 23:36 | 2018-05-29 | CLR | N/A | Hamm Harold | Director, Officer, 10% owner - CEO & Chairman | Other | BUY | $65.30 | 136,000 | $8,880,569 | 1,555,859 | +9.6% |
| 2018-06-01 00:13 | 2018-05-29 | MLNT | N/A | Vatera Healthcare Partners LLC | Director, 10% owner | Other | BUY | $5.00 | 23,257,000 | $116,285,000 | 16,607,959 | +100.0% |
| 2018-06-01 03:46 | 2018-05-30 | MIC | Macquarie Infrastructure Corp | Macquarie Infrastructure Management (USA) INC | Director | Wholesale-Petroleum & Petroleum Products (No Bulk Stations) | BUY | $38.62 | 361,601 | $13,966,043 | 7,761,764 | +4.9% |
| 2018-05-31 23:52 | 2018-05-30 | ITRM | Iterum Therapeutics plc | HUNT RONALD | Director, 10% owner | Pharmaceutical Preparations | BUY | $13.00 | 662,677 | $8,614,801 | 384,615 | +100.0% |
| 2018-05-31 23:10 | 2018-05-29 | KNSA | Kiniksa Pharmaceuticals International, plc | BAKER BROS. ADVISORS LP | Director, 10% owner | Pharmaceutical Preparations | BUY | $18.00 | 3,000,000 | $54,000,000 | 2,700,597 | +100.0% |
| 2018-06-01 00:32 | 2018-05-29 | ETM | N/A | FIELD JOSEPH M | Director, Officer - Chairman Emeritus | Other | BUY | $7.07 | 200,000 | $1,414,600 | 6,677,381 | +3.1% |
| 2018-06-01 04:41 | 2018-05-29 | SRRK | Scholar Rock Holding Corp | Artal International S.C.A. | 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $14.00 | 450,000 | $6,300,000 | 450,000 | +100.0% |
| 2018-05-31 23:19 | 2018-05-29 | KNSA | Kiniksa Pharmaceuticals International, plc | Flynn James E | 10% owner, Other | Pharmaceutical Preparations | BUY | $18.97 | 843,352 | $15,996,869 | 843,352 | +100.0% |
| 2018-05-30 16:59 | 2018-05-29 | IFF | INTERNATIONAL FLAVORS & FRAGRANCES INC | Winder Investment Pte Ltd | 10% owner | Industrial Organic Chemicals | BUY | $124.30 | 100,000 | $12,429,830 | 12,700,000 | +0.8% |
| 2018-05-31 00:25 | 2018-05-30 | ITRM | Iterum Therapeutics plc | CANAAN X L.P. | Director, 10% owner | Pharmaceutical Preparations | BUY | $13.00 | 506,656 | $6,586,528 | 1,733,170 | +41.3% |
| 2018-05-30 23:03 | 2018-05-29 | ECC | Eagle Point Credit Co Inc. | Spinner Daniel M. | Other | Other | BUY | $14,442.00 | 14,625 | $211,214,250 | 89,625 | +19.5% |
| 2018-05-31 00:29 | 2018-05-30 | ITRM | Iterum Therapeutics plc | Malik Shahzad | Director | Pharmaceutical Preparations | BUY | $13.00 | 236,984 | $3,080,792 | 838,325 | +39.4% |
| 2018-05-31 00:15 | 2018-05-30 | ITRM | Iterum Therapeutics plc | Heron Patrick J | Director, 10% owner | Pharmaceutical Preparations | BUY | $13.00 | 456,099 | $5,929,287 | 341,155 | +100.0% |
| 2018-05-30 23:21 | 2018-05-25 | EFX | EQUIFAX INC | Begor Mark W | Director, Officer - CEO | Services-Consumer Credit Reporting, Collection Agencies | BUY | $115.01 | 8,700 | $1,000,627 | 46,491 | +23.0% |
| 2018-05-31 00:26 | 2018-05-30 | ITRM | Iterum Therapeutics plc | Ahrens Brenton Karl | Director | Pharmaceutical Preparations | BUY | $13.00 | 506,656 | $6,586,528 | 1,733,170 | +41.3% |
| 2018-05-31 00:32 | 2018-05-30 | ITRM | Iterum Therapeutics plc | HEALY JAMES | Director, 10% owner | Pharmaceutical Preparations | BUY | $13.00 | 500,000 | $6,500,000 | 1,726,514 | +40.8% |
| 2018-05-31 04:59 | 2018-05-30 | ITRM | Iterum Therapeutics plc | Sofinnova Venture Partners IX, L.P. | 10% owner | Pharmaceutical Preparations | BUY | $13.00 | 500,000 | $6,500,000 | 1,726,514 | +40.8% |
| 2018-05-31 00:37 | 2018-05-25 | RUN | Sunrun Inc. | TIGER GLOBAL MANAGEMENT LLC | 10% owner | Miscellaneous Electrical Machinery, Equipment & Supplies | BUY | $11.11 | 776,138 | $8,619,789 | 11,676,003 | +7.1% |
| 2018-05-30 21:26 | 2018-05-29 | COG | Coterra Energy Inc. | KELLEY ROBERT | Director | Crude Petroleum & Natural Gas | BUY | $22.25 | 50,000 | $1,112,500 | 681,717 | +7.9% |
| 2018-05-31 00:40 | 2018-05-30 | LBTY | Liberty Global Ltd. | FRIES MICHAEL T | Director, Officer - President & CEO | Cable & Other Pay Television Services | BUY | $28.91 | 100,000 | $2,891,270 | 671,905 | +17.5% |
| 2018-05-31 04:07 | 2018-05-25 | IBTX | N/A | SMITH G STACY | Director | Other | BUY | $74.13 | 25,000 | $1,853,305 | 100,000 | +33.3% |
| 2018-05-31 03:53 | 2018-05-25 | LXRX | LEXICON PHARMACEUTICALS, INC. | Invus Public Equities, L.P. | Director, 10% owner | Pharmaceutical Preparations | BUY | $9.94 | 433,378 | $4,306,434 | 1,983,378 | +28.0% |
| 2018-05-30 23:14 | 2018-05-29 | AEF | abrdn Emerging Markets ex-China Fund, Inc. | CITY OF LONDON INVESTMENT GROUP PLC | 10% owner | Other | BUY | $8.49 | 260,100 | $2,208,249 | 513,774 | +102.5% |
| 2018-05-29 13:08 | 2018-05-25 | IFF | INTERNATIONAL FLAVORS & FRAGRANCES INC | Winder Investment Pte Ltd | 10% owner | Industrial Organic Chemicals | BUY | $125.27 | 100,000 | $12,526,500 | 12,600,000 | +0.8% |
| 2018-05-29 22:56 | 2018-05-24 | GOGO | Gogo Inc. | TOWNSEND CHARLES C | Director | Communications Services, NEC | BUY | $4.98 | 359,267 | $1,789,904 | 1,979,611 | +22.2% |
| 2018-05-30 00:44 | 2014-05-17 | TCRD | N/A | Olson Terrence W. | Officer - COO & CFO | Other | BUY | $7.84 | 370,340 | $2,902,762 | 465,285 | +390.1% |
| 2018-05-30 02:37 | 2018-05-24 | MIC | Macquarie Infrastructure Corp | Macquarie Infrastructure Management (USA) INC | Director | Wholesale-Petroleum & Petroleum Products (No Bulk Stations) | BUY | $37.90 | 266,226 | $10,090,737 | 7,400,163 | +3.7% |
| 2018-05-29 23:06 | 2018-05-24 | ITRI | ITRON, INC. | SCOPIA CAPITAL MANAGEMENT LP | 10% owner | Instruments For Meas & Testing of Electricity & Elec Signals | BUY | $59.43 | 20,000 | $1,188,672 | 5,484,889 | +0.4% |
| 2018-05-29 23:59 | 2018-05-24 | VTVT | vTv Therapeutics Inc. | PERELMAN RONALD O | 10% owner | Pharmaceutical Preparations | BUY | $4.38 | 570,776 | $2,499,999 | 3,186,442 | +21.8% |
| 2018-05-29 23:34 | 2018-05-25 | MYOK | N/A | Sanofi | 10% owner | Other | BUY | $49.00 | 150,000 | $7,350,000 | 4,168,899 | +3.7% |
| 2018-05-30 00:10 | 2018-05-24 | ALGN | Align Technology, Inc. | GEORGE ROGER E | Officer - SVP, Legal Affairs & GC | Orthopedic, Prosthetic & Surgical Appliances & Supplies | BUY | $313.23 | 3,537 | $1,107,904 | 4,596 | +334.0% |
| 2018-05-25 17:47 | 2018-05-24 | IFF | INTERNATIONAL FLAVORS & FRAGRANCES INC | Winder Investment Pte Ltd | 10% owner | Industrial Organic Chemicals | BUY | $124.66 | 100,000 | $12,466,450 | 12,500,000 | +0.8% |
| 2018-05-25 18:33 | 2018-05-25 | N-A | Crescent Capital BDC, Inc. | Texas County & District Retirement System | 10% owner | Other | BUY | $20.16 | 549,352 | $11,076,588 | 2,383,487 | +30.0% |
| 2018-05-25 19:10 | 2018-05-23 | QTS | N/A | Williams Chad L. | Officer - Chief Executive Officer | Other | BUY | $35.68 | 50,000 | $1,784,000 | 308,528 | +19.3% |
| 2018-05-25 23:14 | 2018-05-11 | ZIVO | Zivo Bioscience, Inc. | STROME MARK E | 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $0.10 | 13,088,129 | $1,308,813 | 13,088,129 | +100.0% |
| 2018-05-24 13:08 | 2018-05-23 | IFF | INTERNATIONAL FLAVORS & FRAGRANCES INC | Winder Investment Pte Ltd | 10% owner | Industrial Organic Chemicals | BUY | $124.81 | 100,000 | $12,481,100 | 12,400,000 | +0.8% |
| 2018-05-24 15:37 | 2018-05-23 | N-A | N/A | STRS OHIO | 10% owner | Other | BUY | $15.00 | 259,964 | $3,899,460 | 16,027,575 | +1.6% |
| 2018-05-24 22:32 | 2018-05-22 | EVFM | Evofem Biosciences, Inc. | Invesco Ltd. | 10% owner | Pharmaceutical Preparations | BUY | $4.69 | 2,127,659 | $9,978,721 | 9,165,157 | +30.2% |
| 2018-05-24 23:14 | 2018-05-22 | ECC | Eagle Point Credit Co Inc. | Spinner Daniel M. | Other | Other | BUY | $73,933.00 | 75,000 | $5,544,975,000 | 75,000 | +100.0% |
| 2018-05-24 23:21 | 2018-05-24 | ECC | Eagle Point Credit Co Inc. | Majewski Thomas P. | Director, Officer, Other - Chief Executive Officer | Other | BUY | $49,500.00 | 50,000 | $2,475,000,000 | 50,000 | +100.0% |
| 2018-05-25 00:16 | 2018-05-23 | CDTX | Cidara Therapeutics, Inc. | Stein Jeffrey | Director, Officer - President & CEO | Biological Products, (No Diagnostic Substances) | BUY | $4.70 | 212,766 | $1,000,000 | 268,320 | +383.0% |
| 2018-05-25 02:58 | 2018-05-10 | GFN | N/A | Havner Family Trust | 10% owner | Other | BUY | $11.01 | 215,000 | $2,366,871 | 2,800,000 | +8.3% |
| 2018-05-25 02:52 | 2018-05-10 | GFN | N/A | Havner LeeAnn R | 10% owner | Other | BUY | $11.01 | 215,000 | $2,366,871 | 2,809,500 | +8.3% |
| 2018-05-24 23:09 | 2018-05-22 | ITRI | ITRON, INC. | SCOPIA CAPITAL MANAGEMENT LP | 10% owner | Instruments For Meas & Testing of Electricity & Elec Signals | BUY | $59.66 | 128,620 | $7,673,070 | 5,464,889 | +2.4% |
| 2018-05-24 21:29 | 2018-05-23 | RDUS | N/A | BIOTECH GROWTH N V | 10% owner | Other | BUY | $28.91 | 40,000 | $1,156,320 | 6,150,913 | +0.7% |
Institutional Conviction in Form 4
Tracking these institutional-scale purchases allows you to follow the "smart money" when their conviction is highest. When an executive or a 10% beneficial owner commits a seven-figure sum to an open-market transaction, it bypasses the routine noise of stock-based compensation. These trades are often a precursor to major corporate developments or a signal that management views the current market valuation as significantly disconnected from the company’s internal growth trajectory. By monitoring these high-value entries, investors can align their portfolios with the capital of those who possess the most intimate understanding of a business's long-term health and potential.
Filtering the Market Noise
Our platform is designed to eliminate the noise and focus strictly on high-impact accumulation from directors and CEOs betting big on their company’s future. The SEC EDGAR database is frequently flooded with thousands of automated Form 4 filings, many of which involve small, technical, or pre-scheduled trades that offer little predictive value for the average investor. By applying a strict $1,000,000 minimum threshold, we isolate the transactions where insiders are taking substantial personal financial risk. This high-conviction filter serves as a powerful transparency tool, identifying the exact moments when corporate leadership moves away from passive ownership toward aggressive capital deployment.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.